Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MadreNatura is a Swiss-incorporated baby and toddler nutrition company created in 2019 as a joint venture between Hero Group and Angelini Holding to enter the Italian infant food market. The company commercialized the Hero Solo line, a portfolio of 100% organic baby food products sold in Italy through pharmacies, baby specialist stores, selected grocery retailers, drugstores, and e-commerce channels. In May 2025, Hero Group acquired Angelini Holding's remaining 50% stake and took full ownership of MadreNatura. MadreNatura is therefore an active, commercially operating nutrition business rather than a drug-development biotech or pharma company. Its focus is consumer infant nutrition and organic baby food, not therapeutics, clinical-stage medicines, or proprietary drug platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MadreNatura.